Barclays Posts 18 Profit Jump Upgrades FullYear Income Guidance Wholesale Inflation Accelerates April PPI Posts 6 Annual Gain Largest Since 2022 Workday Shares Rise as AI Integration Drives Margin Forecast Upgrade Amazon UK Chief Criticizes Education System Over Youth Unemployment Ferrari Shares Dip Following Electric Vehicle Unveiling Memorial Day Promotions Test Consumer Selectivity Retailers Navigate Cautious Spending iBio Inc IBIO Q1 2026 Earnings EPS Miss on Higher RD Spend Stock Rises Despite No Revenue AMGN Q1 2026 Earnings EPS Surpasses Estimates by 614 Stock Edges Higher BranchOut Food Inc BOF Q1 2026 Earnings Wider Loss Reported as Revenue Remains Undisclosed DGX Q1 2026 Earnings EPS beats estimates by 553 amid steady operational performance MZTI Q1 2026 Earnings EPS Falls 16 Short of Estimates Stock Edges Lower VRME Q4 2025 Earnings EPS Misses Estimates as Loss Per Share Widens Nomad Foods Shows Resilience as Shares Edge Higher NOMD Trading Near Key Resistance Pinnacle Food Group Limited PFAI Holds Near Support After Modest Pullback Pulmatrix Inc PULM Faces Modest Decline as Stock Tests Key Support Levels Vinci Compass Investments Ltd VINP Faces Selling Pressure as Shares Decline Nearly 3 Blackrock Health Sciences Trust BME Edges Higher Testing Key Resistance Zone Oxford Lane Capital 2029 Preferred Shares OXLCO Hold Steady as FixedIncome Market Finds Footing CytoMed Therapeutics GDTC Drops 738 Key Support Levels in Focus Amid Selling Pressure Brilliant Earth Group BRLT Jumps 4 Approaching Key Resistance at 137 Climb Bio Inc CLYM Advances 3 as Biotech Momentum Builds Brookfield Business Corporation BBUC Edges Lower as Market Weighs Sector Pressures Black Spade Acquisition III Co BIII Holds Steady at 992 as SPAC Awaits Business Combination Catalyst Consumer Credit Growth Surges in December Signaling Strong Consumer Spending Power REIT PW Q2 2025 Earnings Positive EPS of 012 Drives Stock Higher QXO Inc QXO Faces Pressure Testing Key Support Levels After 2 Decline CNTY Q1 2026 Earnings EPS Surpasses Estimate Despite Net Loss Prime Medicine Inc PRME Q1 2026 Earnings WiderthanExpected Loss Highlights PreRevenue Development Phase Edgewise Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Progress Continues SCNX Q1 2026 Earnings Narrowerthanexpected loss drives positive surprise despite revenue absence BNC Q3 2023 Earnings Loss per Share of 010 as Company Continues Development Stage Operations LEN Q1 2026 Earnings EPS Misses Estimates as Housing Market Pressures Persist Almonty Industries Q1 2026 Earnings EPS Misses Estimates as Loss Widens Shares Decline